IL15RA and neoplasm: Both human IL-15 (200 μg/kg) and murine IL-15 (3 g/kg) treatment promote CD215+ myeloid cells in B16F10-bearing C57BL/6 mice, and these CD215+ myeloid cells were sorted and shown to promote tumor growth in cell culture systems.